The slip
PARKINSON RECEIPTno. 2083
18 Oct 2026, 13:39 UTCdopamine neurons, braak
predictionZNF217 in dopamine neurons tracks Braak Lewy-body stage
registeredd16b4f3b84631ebc
discovery-0.34 p=0.378 n=9
replication-0.38 p=0.316 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.34, p 0.378)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT72b61c9fd3445846fabac93a…
follows 803911d9ef1e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2083: ZNF217 in dopamine neurons, braak
- power
- full sample -0.21 (p 0.393, n 18), 95% CI -0.62 to +0.28. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.23 (p 0.355, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.34 (p 0.161, n 18). could be the mix.
- skeptic
- leave-one-out range -0.31 to -0.11, sign flips 0; without severely affected donors -0.21 (p 0.393, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF217 in dopamine neurons.
case closed: nothing better to follow up.